Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B

Journal of Clinical Investigation

Volumn 123, Issue 9, 2013, Pages 3728-3739

  Publicover, Jean ^a   Gaggar, Anuj ^a   Nishimura, Stephen ^a   Van Horn, Christine M ^a,f   Goodsell, Amanda ^a   Muench, Marcus O ^a,b   Reinhardt, R Lee ^a,e   Van Rooijen, Nico ^c   Wakil, Adil E ^d   Peters, Marion ^a   Cyster, Jason G ^a   Erle, David J ^a   Rosenthal, Philip ^a   Cooper, Stewart ^a,d   Baron, Jody L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CXCL13 PROTEIN, HUMAN; CXCR5 PROTEIN, HUMAN; INTERLEUKIN 21; INTERLEUKIN DERIVATIVE; TRANSCRIPTOME;

ADAPTIVE IMMUNITY; ADULT; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; INFANT; INFECTION CONTROL; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; ANIMAL; C57BL MOUSE; DISEASE RESISTANCE; DNA MICROARRAY; HEPATITIS B VIRUS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER; LYMPHOID TISSUE; METABOLISM; PATHOLOGY; SPLEEN; VIROLOGY;

ADULT; AGE FACTORS; ANIMALS; CHEMOKINE CXCL13; DISEASE RESISTANCE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, INNATE; INFANT; INTERLEUKINS; LIVER; LYMPHOID TISSUE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CXCR5; SPLEEN; TRANSCRIPTOME;

EID: 84883521409     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI68182     Document Type: Article

References (42)

1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733- 1745. (Pubitemid 27527771)
2. Robinson WS. Principles and Practice of Infectious Diseases. 4th ed. London, United Kingdom: Churchill Livingstone; 1995.
3. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med. 2004;350(11):1118-1129. (Pubitemid 38298992)
4. Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 suppl):S13-S21.
5. Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future challenges. QJM. 2012;105(2):109-113.
6. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut. 2012;61(12):1754-1764.
7. Dandri M, Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut. 2012;61(suppl 1):i6-i17.
8. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010;58(4):258-266.
9. Publicover J, et al. Interleukin-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest. 2011;121(3):1154-1162.
10. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68(5):869-877.
11. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 2002;16(4):583-594. (Pubitemid 34442582)
12. Hultkrantz S, Ostman S, Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology. 2005;116(3):362-372. (Pubitemid 41532127)
13. Van Rooijen N, Sanders A. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology. 1996;23(5):1239-1243. (Pubitemid 26137072)
14. Hardtke S, Ohl L, Forster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood. 2005;106(6):1924-1931. (Pubitemid 41291702)
15. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev. 2003;195:117-135. (Pubitemid 37153458)
16. Junt T, et al. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J Immunol. 2005;175(11):7109-7116. (Pubitemid 41713403)
17. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87(6):1037-1047. (Pubitemid 26427987)
18. Voigt I, Camacho SA, de Boer BA, Lipp M, Forster R, Berek C. CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone. Eur J Immunol. 2000;30(2):560-567. (Pubitemid 30098849)
19. Calne RY. Immunological tolerance - the liver effect. Immunol Rev. 2000;174:280-282. (Pubitemid 30201395)
20. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev. 2000;174:21-34. (Pubitemid 30201376)
21. Sato K, Yabuki K, Haba T, Maekawa T. Role of Kupffer cells in the induction of tolerance after liver transplantation. J Surg Res. 1996;63(2):433-438. (Pubitemid 26239411)
22. Crispe IN. Liver antigen-presenting cells. J Hepatol. 2011;54(2):357-365.
23. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol. 2009;27:147-163.
24. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010;10(11):753-766.
25. Wuensch SA, Pierce RH, Crispe IN. Local intrahepatic CD8+ T cell activation by a non-self-antigen results in full functional differentiation. J Immunol. 2006;177(3):1689-1697. (Pubitemid 44092505)
26. Greter M, Hofmann J, Becher B. Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol. 2009;7(5):e1000109.
27. Klein I, Crispe IN. Complete differentiation of CD8+ T cells activated locally within the transplanted liver. J Exp Med. 2006;203(2):437-447. (Pubitemid 43290852)
28. Derkow K, et al. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis. Hepatology. 2007;46(4):1155- 1165. (Pubitemid 350144780)
29. Ciavarra RP, Buhrer K, Van Rooijen N, Tedeschi B. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells. J Immunol. 1997;158(4):1749-1755. (Pubitemid 127469530)
30. Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, Schwendener RA. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol. 1997;27(10):2626-2633. (Pubitemid 27453853)
31. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006;12(46):7413-7420. (Pubitemid 46017736)
32. Lang PA, et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology. 2010;52(1):25-32.
33. Sitia G, et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 2011;7(6):e1002061.
34. Burgio VL, Ballardini G, Artini M, Caratozzolo M, Bianchi FB, Levrero M. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology. 1998;27(6):1600-1606. (Pubitemid 28264685)
35. Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104(10):3021-3027. (Pubitemid 39507115)
36. Moreth K, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest. 2010;120(12):4251-4272.
37. Schiffer L, et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008;180(3):1938- 1947.
38. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 2002;16(1):67-76. (Pubitemid 34143217)
39. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A. 2004;101(17):6669-6674. (Pubitemid 38586032)
40. Huang LR, et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol. 2013;14(6):574-583.
41. Chisari FV, et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol. 1986;60(3):880-887. (Pubitemid 17179261)
42. Ansel KM, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000;406(6793):309-314. (Pubitemid 30604409)